Some considerations about the value based pricing in oncology: an analysis on metastatic first line medicinal products

Spandonaro, Federico; Giannarelli, Diana; Polistena, Barbara

doi:10.5301/GRHTA.5000218

Record: found
Abstract: found
Article: found

Some considerations about the value based pricing in oncology: an analysis on metastatic first line medicinal products

Author(s): Federico Spandonaro , Diana Giannarelli , Barbara Polistena

Publication date (Electronic): February 11 2016

Journal: Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish

Publisher: SAGE Publications

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish

Abbreviated Title: GRHTA

Publisher: SAGE Publications

ISSN (Print): 2284-2403

Publication date Created: 2016

Publication date (Print): 2016

Publication date (Electronic): February 11 2016

Volume: 3

Issue: 1

Pages: 9-15

Article

DOI: 10.5301/GRHTA.5000218

SO-VID: af2cfb66-21f4-4efb-aeb1-cfe4e5fc44ac

History

Data availability:

To submit your article in one of the AboutScience Journals, please check the Submission Guidelines - AboutScience.

Some considerations about the value based pricing in oncology: an analysis on metastatic first line medicinal products

Read this article at

Related collections

AboutScience

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 2,750

Cited by 1